Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies

13 Feb 2023

Abstract excerpt

BACKGROUND: As the technology of next generation sequencing rapidly develops and costs are constantly reduced, the clinical availability of whole genome sequencing (WGS) increases. Thereby, it remains unclear what exact advantage WGS offers in comparison to whole exome sequencing (WES) for the diagnosis of genetic diseases using current technologies. METHODS: Trio-WGS was conducted for 20 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epilepsy research and treatment
Share to Genomic variations and chromosomal abnormalities
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36785910
DOI: 10.1002/mgg3.2148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathiesPMID 36785910Read ↗

Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic EncephalopathiesSemantic proximity Read ↗

Yield of exome sequencing in patients with developmental and epileptic encephalopathies and inconclusive targeted gene panel.Semantic proximity Read ↗

Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late.Semantic proximity Read ↗

Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.Semantic proximity Read ↗

Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practiceSemantic proximity Read ↗

The utility of whole exome sequencing for identification of the molecular etiology in autosomal recessive developmental and epileptic encephalopathies.Semantic proximity Read ↗

Genome sequencing boosts diagnostic yield for the developmental and epileptic encephalopathiesSemantic proximity Read ↗

Whole Exome Sequencing as a First-Line Molecular Genetic Test in Developmental and Epileptic EncephalopathiesSemantic proximity Read ↗

Clinical application of whole-exome sequencing analysis in childhood epilepsy.Semantic proximity Read ↗

Diagnostic yield and treatment impact of whole-genome sequencing in paediatric neurological disorders.Semantic proximity Read ↗

Optical genome mapping identifies previously undetected causal variants in early-onset developmental epileptic encephalopathies.Semantic proximity Read ↗

Whole Exome Sequencing Based Diagnostics in Complex Childhood Epilepsy Syndromes-A Cohort Study on Clinical Utility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.